Cancer Family
Malignant Head and Neck Neoplasm
CI-CAN-00000236Explore in graph →
1,431 active trials17 approved drugs142 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000236Explore in graph →
Clinical trials
5,448 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (629)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00965003 | MRI Laryngeal Imaging With a Surface Coil | terminated | Early Phase 1 | 3 | Stanford UniversityOTHER | 1 | Oct 5, 2017 | clinicaltrials |
| NCT02538627 | Phase 1 Combination Study of MM-151 With MM-121, MM-141, or Trametinib | terminated | Phase 1 | 5 | Merrimack PharmaceuticalsINDUSTRY | 1 | Sep 5, 2017 | clinicaltrials |
| NCT02437513 |
| NewBreez for Airway Protection in Head and Neck Cancer Patients With Chronic Aspiration |
| terminated |
| — |
| 2 |
| ProTiP MedicalINDUSTRY |
| 0 |
| Aug 24, 2017 |
| clinicaltrials |
| NCT02778412 | ctDNA in Patients With Thyroid Nodules | terminated | — | 66 | Pathway GenomicsINDUSTRY | 1 | Aug 21, 2017 | clinicaltrials |
| NCT01114256 | FNA Tumor Sampling for CD137 Modulation: A Pilot Study | terminated | — | 83 | Stanford UniversityOTHER | 1 | Aug 3, 2017 | clinicaltrials |
| NCT00503776 | Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia | terminated | Phase 2 | 41 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Jun 20, 2017 | clinicaltrials |
| NCT00591149 | Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck Cancer | terminated | Phase 2 | 16 | University of Kansas Medical CenterOTHER | 1 | Jun 14, 2017 | clinicaltrials |
| NCT01303237 | A Post Marketing Surveillance Study to Assess the Safety and Efficacy of Cetuximab Plus Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck(PMS LAD SCCHN) | terminated | — | 88 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 1 | Jun 9, 2017 | clinicaltrials |
| NCT03161548 | A Study of Tongue Conservation Surgery for Oral Tongue Cancer | terminated | Phase 2 | 23 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 0 | May 30, 2017 | clinicaltrials |
| NCT01794845 | Cetuximab + Taxotere With Low Dose Fractionated Radiation for Head and Neck Carcinoma | terminated | Phase 2 | 5 | University of MiamiOTHER | 1 | May 11, 2017 | clinicaltrials |
| NCT02196168 | Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer | terminated | Phase 2 | 6 | National Cancer Institute (NCI)NIH | 1 | May 3, 2017 | clinicaltrials |
| NCT01267240 | Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer | terminated | Phase 2 | 25 | National Cancer Institute (NCI)NIH | 2 | Apr 14, 2017 | clinicaltrials |
| NCT00392665 | Bevacizumab/Tarceva and Tarceva/Sulindac in Squamous Cell Carcinoma of the Head and Neck | terminated | Phase 2 | 36 | Massachusetts General HospitalOTHER | 1 | Apr 13, 2017 | clinicaltrials |
| NCT01865838 | A Study Into the Effect of Seprafilm in Open Total Thyroidectomy | terminated | N/A | 19 | National Cancer Centre, SingaporeOTHER | 1 | Apr 12, 2017 | clinicaltrials |
| NCT00482911 | Lenalidomide, Sunitinib, and Cyclophosphamide in Treating Patients With Stage IV Eye Melanoma | terminated | Phase 2 | 12 | National Institutes of Health Clinical Center (CC)NIH | 1 | Mar 27, 2017 | clinicaltrials |
| NCT00490061 | Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy | terminated | Phase 2 | 17 | Quynh-Thu LeOTHER | 1 | Mar 6, 2017 | clinicaltrials |
| NCT00101075 | Title XELOX FOR SALIVARY GLAND CANCERS | terminated | Phase 2 | 9 | Dana-Farber Cancer InstituteOTHER | 1 | Feb 27, 2017 | clinicaltrials |
| NCT00903461 | Safety and Efficacy of Radiation/Cetuximab Plus EGFR Antisense DNA for Head and Neck Squamous Cell Carcinoma | terminated | Phase 1 | 7 | University of PittsburghOTHER | 1 | Feb 15, 2017 | clinicaltrials |
| NCT00797290 | Photon/Proton Radiation Therapy for Carcinoma of the Nasopharynx(NP01) | terminated | — | 9 | University of FloridaOTHER | 1 | Feb 10, 2017 | clinicaltrials |
| NCT02402348 | Pilot Study of Metformin in HNSCC to Investigate the Effects of MF, Tumor Genotype and MF-genotype Interactions, on Tumor Metabolism and Anoikis | terminated | Early Phase 1 | 3 | West Virginia UniversityOTHER | 1 | Feb 8, 2017 | clinicaltrials |
| NCT00797446 | Photon/Proton Radiation Therapy for Oropharyngeal Cancers(OP01) | terminated | — | 10 | University of FloridaOTHER | 1 | Feb 7, 2017 | clinicaltrials |
| NCT00256295 | Weekly Oxaliplatin and Gemcitabine for Recurrent or Metastatic Head and Neck Cancer | terminated | Phase 2 | 8 | Sai-Hong Ignatius OuOTHER | 1 | Feb 1, 2017 | clinicaltrials |
| NCT00927147 | Boron Neutron Capture Therapy (BNCT) Combined With Cetuximab in the Treatment of Locally Recurred Head and Neck Cancer | terminated | Phase 1 / Phase 2 | 17 | Boneca CorporationINDUSTRY | 1 | Jan 31, 2017 | clinicaltrials |
| NCT02281006 | Efficacy of Trans-tympanic Injections of a Sodium Thiosulfate Gel to Prevent Cisplatin-induced Ototoxicity(STS001) | terminated | Phase 2 | 13 | CHU de Quebec-Universite LavalOTHER | 1 | Jan 27, 2017 | clinicaltrials |
| NCT02331875 | Efficacy Study of Pre-operative IPH2201 in Patients With Squamous Cell Carcinoma of the Oral Cavity | terminated | Phase 1 / Phase 2 | 3 | Innate PharmaINDUSTRY | 2 | Jan 4, 2017 | clinicaltrials |
| NCT00412217 | A Study of Erlotinib (Tarceva) in Participants With Resected Head and Neck Squamous Cell Cancer | terminated | Phase 3 | 94 | Hoffmann-La RocheINDUSTRY | 1 | Nov 25, 2016 | clinicaltrials |
| NCT01507467 | IAEA-HypoX. Accelerated Radiotherapy With or Without Nimorazole in Squamous Cell Carcinoma of the Head and Neck(IAEA-HypoX) | terminated | Phase 3 | 104 | Danish Head and Neck Cancer GroupNETWORK | 4 | Nov 25, 2016 | clinicaltrials |
| NCT00721539 | Assessing the da Vinci® Robotic Surgical System for Surgery of the Upper Aerodigestive Tract | terminated | N/A | 9 | Stanford UniversityOTHER | 1 | Nov 3, 2016 | clinicaltrials |
| NCT01283178 | Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCC | terminated | Phase 1 | 3 | Virginia Commonwealth UniversityOTHER | 1 | Oct 31, 2016 | clinicaltrials |
| NCT01910753 | Physical Activity Program and Nutrition Therapeutic Education During Treatment of Head and Neck Cancer Population(APANVADS) | terminated | N/A | 10 | University Hospital, LimogesOTHER | 1 | Sep 7, 2016 | clinicaltrials |
| NCT01405846 | Feasibility Study to Estimate Number of Patients With Precancerous Areas in Their Airways and the Response to Gefitinib(TIDAL1) | terminated | Phase 2 | 32 | Papworth Hospital NHS Foundation TrustOTHER_GOV | 1 | Aug 19, 2016 | clinicaltrials |
| NCT01975688 | A Pharmacokinetic Study of Single Doses of Sativex in Treatment-induced Mucositis | terminated | Phase 1 | 10 | GW Pharmaceuticals LtdINDUSTRY | 1 | Aug 11, 2016 | clinicaltrials |
| NCT01528137 | Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer | terminated | Phase 1 | 4 | Stanford UniversityOTHER | 1 | Aug 2, 2016 | clinicaltrials |
| NCT02334319 | Ganetespib Window of Opportunity Study in Head and Neck Cancers | terminated | Phase 1 | 3 | Emory UniversityOTHER | 1 | Jul 26, 2016 | clinicaltrials |
| NCT01137162 | Clinical and Pathologic Studies of Patients Undergoing Treatment With EGFR Inhibitors | terminated | — | 10 | Stanford UniversityOTHER | 1 | Jul 22, 2016 | clinicaltrials |
| NCT01403324 | Comparison of Dosimetry After rhTSH or Withdrawal of Thyroid Hormone in Metastatic or Locally Advanced Thyroid Cancer(DOSIMETA) | terminated | N/A | 4 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Jul 13, 2016 | clinicaltrials |
| NCT00377247 | Active Immunization of Patients With Carcinoma of Oral Cavity or Oropharynx With Autologous Dendritic Cells Transfected With DNA From Autologous Tumor | terminated | Phase 1 | 5 | University of PittsburghOTHER | 1 | Jul 11, 2016 | clinicaltrials |
| NCT02080416 | Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors | terminated | Early Phase 1 | 1 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jun 10, 2016 | clinicaltrials |
| NCT00537199 | OraTest in Combination With Visual Examination and Visual Examination Alone | terminated | Phase 3 | 1 | M.D. Anderson Cancer CenterOTHER | 1 | May 13, 2016 | clinicaltrials |
| NCT00872404 | A Study of CP-751,871 in Patients With Recurrent Squamous Head and Neck Carcinoma | terminated | Phase 2 | 37 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | Apr 20, 2016 | clinicaltrials |
| NCT00623129 | Electroacupuncture in Treating Chronic Dry Mouth Caused By Radiation Therapy in Patients With Head and Neck Cancer | terminated | N/A | 30 | Mayo ClinicOTHER | 1 | Apr 19, 2016 | clinicaltrials |
| NCT00891904 | Radiation Therapy and Cetuximab in Treating Patients With Recurrent Head and Neck Cancer | terminated | N/A | 2 | Roswell Park Cancer InstituteOTHER | 1 | Apr 14, 2016 | clinicaltrials |
| NCT02479178 | A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck(iNSITE2) | terminated | Phase 2 | 73 | BIND TherapeuticsINDUSTRY | 2 | Apr 14, 2016 | clinicaltrials |
| NCT01285635 | A Study of AT-101 in Combination With Docetaxel in Squamous Cell Carcinoma Of The Head and Neck | terminated | Phase 2 | 35 | University of Michigan Rogel Cancer CenterOTHER | 1 | Mar 31, 2016 | clinicaltrials |
| NCT00994201 | Magnetic Resonance Imaging (MRI) in the Assessment of Head and Neck Squamous Cell Carcinoma (HNSCC) Response | terminated | — | 10 | OHSU Knight Cancer InstituteOTHER | 1 | Mar 25, 2016 | clinicaltrials |
| NCT00670397 | Photodynamic Therapy Using HPPH in Treating Patients With Recurrent Dysplasia, Carcinoma in Situ, or Stage I Oral Cavity Cancer | terminated | Phase 1 | 11 | Roswell Park Cancer InstituteOTHER | 1 | Mar 16, 2016 | clinicaltrials |
| NCT01161498 | Study of Safety and Efficacy of Talimogene Laherparepvec With Cisplatin and Radiotherapy for Treatment of Locally Advanced Head and Neck Cancer | terminated | Phase 3 | 5 | BioVex LimitedINDUSTRY | 2 | Feb 8, 2016 | clinicaltrials |
| NCT00272181 | Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer | terminated | Phase 2 | 15 | Sesen Bio, Inc.INDUSTRY | 2 | Dec 23, 2015 | clinicaltrials |
| NCT00412776 | Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer | terminated | Phase 2 / Phase 3 | 165 | Sesen Bio, Inc.INDUSTRY | 18 | Dec 23, 2015 | clinicaltrials |
Data updated 23 days agoSource updated Oct 5, 2017source: clinicaltrials